IL‐10 can be a biomarker for poor disease outcome; higher blood levels of IL‐10 was predictive of BPD/death in a cohort of premature infants (Ambalavanan et al., 2009).Thus, downregulation of IL‐10 by rAPN could be of potential benefit. This evidence concerns the gene IL10 and bronchopulmonary dysplasia.